Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North and South America, Europe and Asia Pacific.

Recent Press Releases

October 21, 2014 - 5:00 p.m.
Gilead Sciences to Release Third Quarter 2014 Financial Results on Tuesday, October 28, 2014Printer Friendly Version 

Upcoming Events

Saturday, October 25, 2014 through Thursday, October 30, 2014
American College of Chest Physicians (CHEST)
Tuesday, October 28, 2014 4:30 p.m. ET
Q3 2014 Gilead Sciences Earnings Conference Call
Friday, November 7, 2014 through Tuesday, November 11, 2014
American Association for the Study of Liver Diseases (AASLD): The Liver Meeting

Most Viewed Links

Updated 10/14/14
1.Stock Information
2.SEC Filings
3.Earnings
4.U.S. Food and Drug Administration Approves Gilead’s Harvoni® (Ledipasvir/Sofosbuvir), the First Once-Daily Single Tablet Regimen for the Treatment of Genotype 1 Chronic Hepatitis C
5.Gilead Announces U.S. FDA Priority Review Designation for Ledipasvir/Sofosbuvir Fixed-Dose Combination Tablet for Chronic Hepatitis C Genotype 1 Infection
* Data collected 10/06/14 - 10/13/14

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
NASDAQ (US Dollar)
$106.67
 Stock is Up 4.46 (4.36%)
Data as of 10/21/14 4:15 p.m. ET
Minimum 20 minute delay
Refresh Quote
Recent Webcasts